Loading…
Reported covered position: Legis. Counsel, Senator Jim Talent; Counsel, Senate Finance Committee; Prof. Staff, House Education and Workforce Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ACCENDRA HEALTH INC. via ACCENDRA HEALTH INC.
2026 · third_quarter · 3T
Issues related to patient access to home medical equipment and related reimbursement.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Source: Senate LDA
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
DME Scammer Prevention Act of 2026
Client: ACCENDRA HEALTH INC. · Firm: ACCENDRA HEALTH INC.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
DME Scammer Prevention Act of 2026
Client: ACCENDRA HEALTH INC. · Firm: ACCENDRA HEALTH INC.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
DME Scammer Prevention Act of 2026
Client: ACCENDRA HEALTH INC. · Firm: ACCENDRA HEALTH INC.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Protecting American Consumers from Robocalls Act
Client: ACCENDRA HEALTH INC. · Firm: ACCENDRA HEALTH INC.
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to competitive bidding for home medical equipment; patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Issues related to patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2024, 118th Congress H.R. 7829, S. 3821); the extension of telehealth flexibilities (see Public Law No. 119-4); and promoting electronic prescribing platforms.
Issues related to competitive bidding for home medical equipment; patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Issues related to competitive bidding for home medical equipment; patient access to home respiratory services including oxygen therapy and related reimbursement (i.e., the Supplemental Oxygen Access Reform ["SOAR"] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to competitive bidding for home medical equipment; patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Issues related to competitive bidding for home medical equipment; patient access to home respiratory services including oxygen therapy and related reimbursement (i.e., the Supplemental Oxygen Access Reform ["SOAR"] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Promoting Resilient Supply Chains Act of 2025
Client: ACCENDRA HEALTH INC. · Firm: ACCENDRA HEALTH INC.
Issues related to the medical-surgical supply chain including domestic and near-shore production including the Pandemic and All-Hazards Preparedness Act (Public Law No. 109-417); Promoting Resilient Supply Chains Act of 2025 (S. 257).
Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Issues related to patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2024, 118th Congress H.R. 7829, S. 3821); the extension of telehealth flexibilities (see Public Law No. 119-4); and promoting electronic prescribing platforms.
Issues related to patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2024, 118th Congress H.R. 7829, S. 3821); the extension of telehealth flexibilities (see Public Law No. 119-4); and promoting electronic prescribing platforms.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333).
Preparing for All Hazards and Pathogens Reauthorization Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333); see also Public Law No: 118-158.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333).
Preparing for All Hazards and Pathogens Reauthorization Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421).
DRA of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
DRA of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), Consolidated Appropriations Act, 2024 (P.L. 118-42), Further Consolidated Appropriations Act, 2024 (P.L. 118-47), and Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (S. 3821).
DRA of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821); the Improving Seniors' Timely Access to Care Act (H.R. 8702, S. 4532); and extension of certain telehealth flexibilities (see Public Law No: 118-158).
DRA of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
FAST PASS Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
FY 25 National Defense Authorization Act (Public Law No: 118-31) provisions to expedite medical-surgical supplies (see the Facilitate Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation [FAST PASS] Act, H.R. 6140).
SOAR Act of 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
SOAR Act of 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821); the Improving Seniors' Timely Access to Care Act (H.R. 8702, S. 4532); and extension of certain telehealth flexibilities (see Public Law No: 118-158).
SOAR Act of 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
FY 2025 National Defense Authorization Act (H.R. 8070, S. 2226) and issues related to production and acquisition of medical personal protective equipment (PPE).
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
FY 2025 National Defense Authorization Act (H.R. 8070, S. 2226) and issues related to production and acquisition of medical personal protective equipment (PPE).
Improving Seniors’ Timely Access to Care Act of 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821); the Improving Seniors' Timely Access to Care Act (H.R. 8702, S. 4532); and extension of certain telehealth flexibilities (see Public Law No: 118-158).
Competitive Bidding Relief Act of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
Competitive Bidding Relief Act of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
Competitive Bidding Relief Act of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821); the Improving Seniors' Timely Access to Care Act (H.R. 8702, S. 4532); and extension of certain telehealth flexibilities (see Public Law No: 118-158).
Competitive Bidding Relief Act of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), Consolidated Appropriations Act, 2024 (P.L. 118-42), Further Consolidated Appropriations Act, 2024 (P.L. 118-47), and Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (S. 3821).
National Defense Authorization Act for Fiscal Year 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
FY 2025 National Defense Authorization Act (H.R. 8070, S. 2226) and issues related to production and acquisition of medical personal protective equipment (PPE).
National Defense Authorization Act for Fiscal Year 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
FY 2025 National Defense Authorization Act (H.R. 8070, S. 2226) and issues related to production and acquisition of medical personal protective equipment (PPE).
Pandemic and All-Hazards Preparedness and Response Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333).
Pandemic and All-Hazards Preparedness and Response Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333).
Pandemic and All-Hazards Preparedness and Response Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333); see also Public Law No: 118-158.
SOAR Act of 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
SOAR Act of 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), Consolidated Appropriations Act, 2024 (P.L. 118-42), Further Consolidated Appropriations Act, 2024 (P.L. 118-47), and Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (S. 3821).
SOAR Act of 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
SOAR Act of 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821); the Improving Seniors' Timely Access to Care Act (H.R. 8702, S. 4532); and extension of certain telehealth flexibilities (see Public Law No: 118-158).
Improving Seniors’ Timely Access to Care Act of 2024
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821); the Improving Seniors' Timely Access to Care Act (H.R. 8702, S. 4532); and extension of certain telehealth flexibilities (see Public Law No: 118-158).
Preparing for All Hazards and Pathogens Reauthorization Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and FDA regulation of medical-surgical supplies; and legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA) to include the Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421).
Preparing for All Hazards and Pathogens Reauthorization Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and FDA regulation of medical-surgical supplies; and legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA) to include the Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421).
DRA of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the DMEPOS Relief Act of 2023 (H.R. 5555) and the Competitive Bidding Relief Act of 2023 (S. 1294); and electronic documentation for home respiratory therapy services.
DRA of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the DMEPOS Relief Act of 2023 (H.R. 5555) and the Competitive Bidding Relief Act of 2023 (S. 1294); and electronic documentation for home respiratory therapy services.
Competitive Bidding Relief Act of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the DMEPOS Relief Act of 2023 (H.R. 5555) and the Competitive Bidding Relief Act of 2023 (S. 1294); and electronic documentation for home respiratory therapy services.
Competitive Bidding Relief Act of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the DMEPOS Relief Act of 2023 (H.R. 5555) and the Competitive Bidding Relief Act of 2023 (S. 1294); and electronic documentation for home respiratory therapy services.
Competitive Bidding Relief Act of 2023
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the Competitive Bidding Relief Act of 2023 (S. 1294), and the end of the Covid-19 Public Health Emergency including electronic documentation for home respiratory therapy services.
DRA of 2022
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues relating to durable medical equipment (DME) including Medicare reimbursement, extending DME non-Competitive Bidding Area relief included in the "CARES" Act of 2020 (Pub. Law 116-136) and DMEPOS Relief Act of 2022 (H.R. 6641, 117th Congress); and issues related to the covid-19 public health emergency including for home respiratory therapy and diabetes supply coverage and documentation.
PREVENT Pandemics Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain and covid-19; support for onshore and near-shore sourcing of medical-surgical supplies; issues related to the "PREVENT" Pandemics Act (S. 3799, 117th Congress) and the Consolidated Appropriations Act, 2022 (Pub. Law 117-328).
PREVENT Pandemics Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues related to the medical-surgical supply chain and covid-19; support for onshore and near-shore sourcing of medical-surgical supplies; issues related to the "PREVENT" Pandemics Act (S. 3799, 117th Congress) and the Consolidated Appropriations Act, 2022 (Pub. Law 117-328).
PPE in America Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Expanded Telehealth Access Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues relating to durable medical equipment (DME) including Medicare reimbursement, sequestration and "PAYGO" relief, extending DME non-Competitive Bidding area relief included in the "CARES" Act of 2020 (Pub. Law 116-136); issues related to the COVID-19 public health emergency including for home respiratory therapy coverage and documentation; DMEPOS Relief Act of 2022 (H.R. 6641); Expanded Telehealth Access Act (H.R. 2168); Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
Make PPE in America Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Make PPE in America Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Make PPE in America Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Infrastructure Investment and Jobs Act (Public Law 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260); Coronavirus Aid, Relief, and Economic Security Act (Public Law 116-136); DMEPOS Relief Act of 2022 (H.R. 6641); Statutory Pay-As-You-Go Act of 2010
Medical Supplies for Pandemics Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Medical Supplies for Pandemics Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Strengthening America's Strategic National Stockpile Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Strengthening America's Strategic National Stockpile Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
United States Innovation and Competition Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
United States Innovation and Competition Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
United States Innovation and Competition Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Infrastructure Investment and Jobs Act (Public Law 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260); Coronavirus Aid, Relief, and Economic Security Act (Public Law 116-136); DMEPOS Relief Act of 2022 (H.R. 6641); Statutory Pay-As-You-Go Act of 2010
Masks for All Act of 2022
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
DRA of 2022
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Issues relating to durable medical equipment (DME) including Medicare reimbursement, sequestration and "PAYGO" relief, extending DME non-Competitive Bidding area relief included in the "CARES" Act of 2020 (Pub. Law 116-136); issues related to the COVID-19 public health emergency including for home respiratory therapy coverage and documentation; DMEPOS Relief Act of 2022 (H.R. 6641); Expanded Telehealth Access Act (H.R. 2168); Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
DRA of 2022
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Infrastructure Investment and Jobs Act (Public Law 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260); Coronavirus Aid, Relief, and Economic Security Act (Public Law 116-136); DMEPOS Relief Act of 2022 (H.R. 6641); Statutory Pay-As-You-Go Act of 2010
United States Innovation and Competition Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
United States Innovation and Competition Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
United States Innovation and Competition Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Infrastructure Investment and Jobs Act (Public Law 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260); Coronavirus Aid, Relief, and Economic Security Act (Public Law 116-136); DMEPOS Relief Act of 2022 (H.R. 6641); Statutory Pay-As-You-Go Act of 2010
Make PPE in America Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Make PPE in America Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Make PPE in America Act
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Infrastructure Investment and Jobs Act (Public Law 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260); Coronavirus Aid, Relief, and Economic Security Act (Public Law 116-136); DMEPOS Relief Act of 2022 (H.R. 6641); Statutory Pay-As-You-Go Act of 2010
Medical Supplies for Pandemics Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Medical Supplies for Pandemics Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Strengthening America’s Strategic National Stockpile Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Strengthening America’s Strategic National Stockpile Act of 2021
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Firm: ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
FY 2027 Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCENDRA HEALTH INC. via ACCENDRA HEALTH INC.
2026 · second_quarter · Q2
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
FY 2027 Appropriations.
Issues related to patient access to home medical equipment and related reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACCENDRA HEALTH INC. via ACCENDRA HEALTH INC.
2026 · second_quarter · Q2
Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
FY 2027 Appropriations.
Issues related to patient access to home medical equipment and related reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACCENDRA HEALTH INC. via ACCENDRA HEALTH INC.
2026 · first_quarter · Q1
Issues related to patient access to home medical equipment and related reimbursement.
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
CHAMPVA medical supply reimbursement.
FY 2027 Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCENDRA HEALTH INC. via ACCENDRA HEALTH INC.
2025 · fourth_quarter · Q4
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
FY 2026 Appropriations.
CHAMPVA medical supply reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE
ACCENDRA HEALTH INC. via ACCENDRA HEALTH INC.
2025 · third_quarter · Q3
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
Issues related to competitive bidding for home medical equipment; patient access to home respiratory services including oxygen therapy and related reimbursement (i.e., the Supplemental Oxygen Access Reform ["SOAR"] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
ACCENDRA HEALTH INC. via ACCENDRA HEALTH INC.
2025 · second_quarter · Q2
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution including the Pandemic and All-Hazards Preparedness Act (Public Law No. 109-417).
Issues related to competitive bidding for home medical equipment; patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.
ACCENDRA HEALTH INC. via ACCENDRA HEALTH INC.
2025 · first_quarter · Q1
Issues related to the medical-surgical supply chain including domestic and near-shore production including the Pandemic and All-Hazards Preparedness Act (Public Law No. 109-417); Promoting Resilient Supply Chains Act of 2025 (S. 257).
Issues related to patient access to respiratory therapy including non-invasive ventilation and related reimbursement (see the DMEPOS Relief Act of 2025 [H.R. 2005]; the Supplemental Oxygen Access Reform [SOAR] Act of 2024, 118th Congress H.R. 7829, S. 3821); the extension of telehealth flexibilities (see Public Law No. 119-4); and promoting electronic prescribing platforms.
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2024 · fourth_quarter · Q4
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333); see also Public Law No: 118-158.
FY 25 National Defense Authorization Act (Public Law No: 118-31) provisions to expedite medical-surgical supplies (see the Facilitate Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation [FAST PASS] Act, H.R. 6140).
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2024 · third_quarter · Q3
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333).
Issues related to imported products relevant to the medical-surgical supply chain.
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2024 · second_quarter · Q2
Issues related to the Department of Veterans Affairs' medical-surgical supply chain.
FY 2025 National Defense Authorization Act (H.R. 8070, S. 2226) and issues related to production and acquisition of medical personal protective equipment (PPE).
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), the Competitive Bidding Relief Act of 2023 (S. 1294), and the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821).
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2024 · first_quarter · Q1
Issues related to sterilization of medical-surgical products.
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), Consolidated Appropriations Act, 2024 (P.L. 118-42), Further Consolidated Appropriations Act, 2024 (P.L. 118-47), and Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (S. 3821).
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421).
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2023 · fourth_quarter · Q4
Issues related to medical-surgical supply and equipment sterilization.
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the DMEPOS Relief Act of 2023 (H.R. 5555) and the Competitive Bidding Relief Act of 2023 (S. 1294); and electronic documentation for home respiratory therapy services.
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and FDA regulation of medical-surgical supplies; and legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA) to include the Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421).
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2023 · third_quarter · Q3
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the DMEPOS Relief Act of 2023 (H.R. 5555) and the Competitive Bidding Relief Act of 2023 (S. 1294); and electronic documentation for home respiratory therapy services.
Issues related to medical-surgical supply and equipment sterilization.
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and FDA regulation of medical-surgical supplies; and legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA) to include the Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421).
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2023 · second_quarter · Q2
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing, and the reauthorization of the Pandemic and All-Hazards Preparedness Act (Public Law No. 109-417).
Issues related to expediting critical cargo such as medical equipment at U.S. ports.
Issues related to the sterilization of medical-surgical products.
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2023 · first_quarter · Q1
Issues related to the medical-surgical supply chain and covid-19; support for onshore and near-shore sourcing of medical-surgical supplies; issues related to the "PREVENT" Pandemics Act (S. 3799, 117th Congress) and the Consolidated Appropriations Act, 2022 (Pub. Law 117-328).
Issues related to the medical-surgical supply chain and covid-19; support for onshore and near-shore sourcing of medical-surgical supplies; issues related to the "PREVENT" Pandemics Act (S. 3799, 117th Congress) and the Consolidated Appropriations Act, 2022 (Pub. Law 117-328).
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2022 · fourth_quarter · Q4
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; PREVENT Pandemics Act (S. 3799); Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
Issues relating to durable medical equipment (DME) including Medicare reimbursement, sequestration and "PAYGO" relief, extending DME non-Competitive Bidding area relief included in the "CARES" Act of 2020 (Pub. Law 116-136); issues related to the COVID-19 public health emergency including for home respiratory therapy coverage and documentation; DMEPOS Relief Act of 2022 (H.R. 6641); Expanded Telehealth Access Act (H.R. 2168); Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2022 · third_quarter · Q3
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Infrastructure Investment and Jobs Act (Public Law 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260); Coronavirus Aid, Relief, and Economic Security Act (Public Law 116-136); DMEPOS Relief Act of 2022 (H.R. 6641); Statutory Pay-As-You-Go Act of 2010
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2022 · second_quarter · Q2
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; FY23 Appropriations Funding
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; FY23 Appropriations Funding
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2022 · first_quarter · Q1
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2021 · fourth_quarter · Q4
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306)
National Defense Authorization Act for Fiscal Year 2022 (Public Law No: 117-81); Manufacture and distribution of medical-surgical supplies including PPE products and the provision of solutions and expertise that support U.S. military efforts.
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2021 · third_quarter · Q3
Personal Protective Equipment (PPE) Supply Chain and Manufacture and COVID-19; United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); INVEST in America Act (H.R. 3864)
National Defense Authorization Act for Fiscal Year 2022 (H.R. 4350; S. 2792); Manufacture and distribution of medical-surgical supplies including PPE products and the provision of solutions and expertise that support U.S. military efforts.
Support for Domestic Manufacture and Sourcing of PPE; Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 (H.R. 4502); Department of Homeland Security Appropriations Act, 2022 (H.R. 4431)
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2021 · second_quarter · Q2
National Defense Authorization Act for Fiscal Year 2022: Manufacture and distribution of medical/surgical PPE products and the provision of solutions and expertise that support U.S. military efforts.
Appropriations for medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Addressing U.S. Port Congestion
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2021 · first_quarter · Q1
Manufacture and distribution of medical/surgical PPE products and the provision of solutions and expertise that support critical patient care. PPE supply chain and COVID-19. Strategic National Stockpile. Appropriations for medical/surgical PPE.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") via ACCENDRA HEALTH INC. (FORMERLY "OWENS & MINOR, INC.)
2021 · first_quarter · RR
Legislative and regulatory proposals affecting the healthcare industry, including the manufacture and distribution of surgical and PPE products and the provision of solutions and expertise that support critical patient care.
FY 2026 Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the medical-surgical supply chain including domestic and near-shore production and distribution.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Issues related to the medical-surgical supply chain including domestic and near-shore production.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), the Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (H.R. 7829, S. 3821); the Improving Seniors' Timely Access to Care Act (H.R. 8702, S. 4532); and extension of certain telehealth flexibilities (see Public Law No: 118-158).
Issues related to product imports relevant to the medical-surgical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2025 National Defense Authorization Act (H.R. 8070, S. 2226) and issues related to production and acquisition of medical personal protective equipment (PPE).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421, S. 2333).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the Competitive Bidding Relief Act of 2023 (S. 1294), and the end of the Covid-19 Public Health Emergency including electronic documentation for home respiratory therapy services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to durable medical equipment (DME) including Medicare reimbursement, extending DME non-Competitive Bidding Area relief included in the "CARES" Act of 2020 (Pub. Law 116-136) and DMEPOS Relief Act of 2022 (H.R. 6641, 117th Congress); and issues related to the covid-19 public health emergency including for home respiratory therapy and diabetes supply coverage and documentation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; FY23 Appropriations Funding
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; FY23 Appropriations Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; FY23 Appropriations Funding
Filing targets: Architect of the Capitol (AOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Support for Domestic and Near-Shore Manufacture of PPE; Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 (H.R. 4502); Department of Homeland Security Appropriations Act, 2022 (H.R. 4431)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies including PPE; United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); INVEST in America Act (H.R. 3684)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE